Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Effect of Virtual Reality Distraction on Anxiety, Pain, and Satisfaction in Patients Undergoing Cardiac Catheterization in Palestine (VR during Cath)

10 de novembro de 2026 atualizado por: Murad Abdalkareem Husen Jkhlab, Arab American University (Palestine)

The Effect of Virtual Reality Distraction on Anxiety, Pain, and Satisfaction in Patients Undergoing Cardiac Catheterization in Palestine: A Randomized Controlled Clinical Trial

This randomized controlled trial evaluated the effect of immersive virtual reality (VR) distraction on procedural anxiety, pain, and patient satisfaction among adult patients undergoing cardiac catheterization.

Patients undergoing cardiac catheterization often experience significant anxiety and pain, which can negatively affect procedural outcomes and overall patient satisfaction. Immersive virtual reality has emerged as a promising non-pharmacological nursing intervention to mitigate procedural distress.

Participants were randomized into two groups: an intervention group receiving immersive VR distraction prior to and during the catheterization procedure, and a control group receiving standard nursing care. Procedural anxiety, pain intensity, and overall satisfaction were assessed using validated measurement instruments to determine the efficacy of the intervention.

Visão geral do estudo

Descrição detalhada

Background:

Cardiac catheterization is a widely performed invasive diagnostic and therapeutic procedure. Despite its clinical safety, patients frequently experience high levels of pre-procedural and intra-procedural anxiety and physical pain, which can induce hemodynamic instability and reduce patient satisfaction.

Study Design and Setting:

This study was conducted as a single-center, parallel-group, randomized controlled clinical trial at An-Najah National University Hospital in Nablus, Palestine.

Methods & Procedure:

A total of 92 eligible adult patients scheduled for cardiac catheterization were enrolled and randomly allocated (1:1) to either:

  1. VR Intervention Group: Received immersive virtual reality distraction (using a head-mounted display presenting relaxing virtual environments) delivered before and during the catheterization procedure alongside standard care.
  2. Control Group: Received standard peri-procedural nursing care.

Outcomes & Measurements:

Primary Outcome: Procedural anxiety measured before and after the intervention using a validated anxiety scale. Procedural pain intensity measured via the Numeric Rating Scale (NRS) and overall patient satisfaction assessed post-procedure.

Ethical Considerations:

Ethical approval was granted by the Institutional Review Board at Arab American University (R-2026/A/82/N). All participants provided written informed consent prior to enrollment.

Tipo de estudo

Intervencional

Inscrição (Real)

92

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Nablus
      • Nablus, Nablus, Territórios palestinos, P400
        • An-Najah National University Hospital (NNUH)

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Adults ≥ 18 years undergoing elective diagnostic or interventional cardiac catheterization.
  • Able to understand and provide consent in Arabic.
  • No contraindications to VR (e.g., severe motion sickness, uncontrolled epilepsy).

Exclusion Criteria:

  • Emergency cardiac catheterization.
  • Cognitive impairments that might obstruct participation.
  • Severe visual or auditory impairments incompatible with VR use.
  • History of significant adverse reactions to VR.
  • Previous participation in a VR intervention study related to cardiac procedures
  • A documented history of an anxiety disorder

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Control Group

Patients in this group received standard peri-procedural nursing and medical care before the cardiac catheterization procedure without virtual reality distraction.

Standard clinical and nursing care during cardiac catheterization without virtual reality intervention.

Experimental: VR Intervention Group

VR Intervention Group patients in this group received immersive virtual reality (VR) distraction using a head-mounted display presenting relaxing virtual environments before the cardiac catheterization procedure, alongside standard care.

Experimental VR Intervention Group Patients in this group received immersive virtual reality (VR) distraction using a head-mounted display presenting relaxing virtual environments before the cardiac catheterization procedure, alongside standard care.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
State Anxiety Measured by the State-Trait Anxiety Inventory, State Anxiety Subscale (Form Y-1)
Prazo: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

State anxiety was measured using the Arabic version of the State-Trait Anxiety Inventory, State Anxiety Subscale (Form Y-1), a 20-item self-report questionnaire. Total scores range from 20 (minimum) to 80 (maximum); higher scores indicate greater anxiety (a worse outcome). The between-group difference in change from baseline was assessed at the pre-procedural assessment (immediately after the 15-minute virtual reality session in the intervention group, or after an equivalent routine waiting period in the control group) and at the post-procedural assessment.

Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
Pain Intensity Measured by the Numeric Rating Scale
Prazo: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

Pain intensity was measured using an 11-point Numeric Rating Scale. Scores range from 0 (no pain, minimum) to 10 (worst possible pain, maximum); higher scores indicate greater pain intensity (a worse outcome).

Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
Satisfaction With Nursing Care Measured by the Patient Satisfaction With Nursing Care Quality Questionnaire
Prazo: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

Satisfaction with nursing care was measured using the Arabic version of the Patient Satisfaction With Nursing Care Quality Questionnaire. Each of the 17 items is rated from 1 (poor) to 5 (excellent), and the score is the mean of the items, ranging from 1 (minimum) to 5 (maximum); higher scores indicate greater satisfaction (a better outcome).

Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de setembro de 2026

Conclusão Primária (Real)

20 de outubro de 2026

Conclusão do estudo (Real)

20 de outubro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

6 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

10 de novembro de 2026

Primeira postagem (Real)

13 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

13 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be publicly shared to protect patient privacy and confidentiality in accordance with the institutional review board approvals and informed consent agreements.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever